stockrowGuardant Health, Inc.
GH Healthcare Diagnostics & Research
Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024.
- Revenue
- +36.1%
- EPS
- −25.7%
- Free cash flow
- +18.7%
- Total debt
- +34.8%
Quarter to September 2026, against a year earlier
Follow GH
Alert me
Guardant Health, Inc. (GH) Total debt
Guardant Health, Inc.'s total debt at the end of fiscal 2025 was $1.5B, up 31.6% from $1.1B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $1.5B. Over the past ten years it has ranged from $460.0K (fiscal 2017) to $1.5B (fiscal 2025) — the current reading is the highest in ten years. Guardant Health, Inc. ranks 15th of 46 Diagnostics & Research companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $1.5B | 31.64% |
| FY2024 | $1.1B | 0.23% |
| FY2023 | $1.1B | 0.23% |
| FY2022 | $1.1B | 0.23% |
| FY2021 | $1.1B | 40.75% |
| FY2020 | $806.3M | 1,915.73% |
| FY2019 | $40.0M | 471.43% |
| FY2018 | $7.0M | 1,421.74% |
| FY2017 | $460.0K | (97.29%) |
| FY2016 | $17.0M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $1.5B | (0.04%) |
| Jun 2026 | $1.5B | (0.04%) |
| Mar 2026 | $1.5B | (0.04%) |
| Dec 2025 | $1.5B | 34.94% |
| 29 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| DGX Quest Diagnostics Incorporated compare | $5.6B |
| LH Labcorp Holdings Inc. compare | $5.3B |
| ICLR ICON PLC compare | $3.4B |
| RVTY Revvity Inc. compare | $2.6B |
| CRL Charles River Laboratories International, Inc. compare | $2.4B |
| MTD Mettler-Toledo International, Inc. compare | $2.1B |
| ILMN Illumina, Inc. compare | $1.8B |
| GH Guardant Health, Inc. | $1.5B |
| MEDP Medpace Holdings, Inc. compare | $163.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on GH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement